Upexi (UPXI) Stock Price, News & Analysis

Company Overview

Upexi, Inc. manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.

Key Stats

• Today's Range: $4.90 to $6.22
• 50-Day Range: $2.34 to $8.55
• 52-Week Range: $2.17 to $33.00
• Volume: 540,159 shs
• Average Volume: 2.37 million shs
• Market Capitalization: $5.87 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $25.00
• Consensus Rating: Hold

Upexi Stock Analysis - MarketRank™

Upexi scored higher than 29% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Upexi has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Upexi has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Upexi has a P/B Ratio of 0.18. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

22.07% of the float of Upexi has been sold short.

Short Interest Ratio / Days to Cover

Upexi has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Upexi has recently increased by 837.08%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Upexi does not currently pay a dividend.

Dividend Growth

Upexi does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

22.07% of the float of Upexi has been sold short.

Short Interest Ratio / Days to Cover

Upexi has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Upexi has recently increased by 837.08%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Upexi this week, compared to 0 articles on an average week.

Search Interest

8 people have searched for UPXI on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.

MarketBeat Follows

Only 2 people have added Upexi to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Upexi insiders have not sold or bought any company stock.

Percentage Held by Insiders

38.35% of the stock of Upexi is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 5.68% of the stock of Upexi is held by institutions.

UPXI Stock Analysis - Frequently Asked Questions

How have UPXI shares performed this year?

Upexi's stock was trading at $23.20 at the beginning of the year. Since then, UPXI stock has decreased by 75.7% and is now trading at $5.64.
View the best growth stocks for 2024 here.

How were Upexi's earnings last quarter?

Upexi, Inc. (NASDAQ:UPXI) announced its earnings results on Monday, November, 20th. The company reported ($1.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.80) by $0.60. The business earned $27.35 million during the quarter. Upexi had a negative net margin of 28.34% and a negative trailing twelve-month return on equity of 54.97%.

When did Upexi's stock split?

Shares of Upexi reverse split before market open on Thursday, October 3rd 2024. The 1-20 reverse split was announced on Thursday, October 3rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Upexi?

Shares of UPXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Upexi own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Upexi investors own include Ford Motor (F), Meta Platforms (META), Tesla (TSLA), Walt Disney (DIS), NVIDIA (NVDA), Advanced Micro Devices (AMD) and Devon Energy (DVN).

Company Calendar

• Last Earnings: 11/20/2023
• Today: 11/23/2024
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Medicinals & botanicals
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:UPXI
• CUSIP: N/A
• CIK: 1775194
• Web: groveinc.io
• Phone: 701-353-5425
• Fax: N/A
• Employees: 130
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $25.00
• High Stock Price Target: $25.00
• Low Stock Price Target: $25.00
• Potential Upside/Downside: +343.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-16,930,000.00
• Net Margins: -28.34%
• Pretax Margin: N/A
• Return on Equity: -54.97%
• Return on Assets: -23.24%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $80.68 million
• Price / Sales: 0.07
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $31.00 per share
• Price / Book: 0.18

Miscellaneous

• Outstanding Shares: 1,040,000
• Free Float: 644,000
• Market Cap: $5.87 million
• Optionable: Optionable
• Beta: 0.23